Cargando…
Postoperative chemoradiotherapy improves survival in patients with stage II–III esophageal squamous cell carcinoma: An analysis of clinical outcomes
BACKGROUND: We compared the efficacy of postoperative chemoradiation (POCRT) and surgery alone (SA) in patients with stage II–III esophageal squamous cell carcinoma (ESCC). METHODS: We analyzed the records of 265 patients with stage II–III ESCC who had undergone transthoracic esophagectomy and lymph...
Autores principales: | Zou, Bingwen, Pang, Jing, Liu, Yongmei, Xu, Yong, Li, Lu, Zhou, Lin, Zhu, Jiang, Huang, Meijuan, Wang, Jin, Ren, Li, Gong, Youlin, Lu, You, Chen, Longqi, Peng, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129165/ https://www.ncbi.nlm.nih.gov/pubmed/27766781 http://dx.doi.org/10.1111/1759-7714.12355 |
Ejemplares similares
-
Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022) -
Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
por: Zou, Bingwen, et al.
Publicado: (2020) -
Retracted: Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Longer interval between neoadjuvant chemoradiotherapy and surgery is associated with improved pathological response, but does not accurately estimate survival in patients with resectable esophageal cancer
por: Liu, Jiaqi, et al.
Publicado: (2023) -
Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2012)